Product Search
We provide safer and differentiated healthcare products to customers
by combining medical technologies.
PRODUCT
Binosto effervescent tablet
Print
product information
Binosto effervescent tablet
| Classification | Ethical the Counter(ETC) |
|---|---|
| Major Ingredients | alendronic acid trihydrate |
| Efficacy/Effectiveness | Treatment of postmenopausal osteoporosis |
| Appearance | White to off-white round effervescent tablets |
product information
Details
1) Compositon
Alendronic acid 70mg
2) Indication
Treatment of postmenopausal osteoporosis
3) Dosage & Administration
Posology
The recommended dose is one 70 mg effervescent tablet once weekly.
Patients should be instructed that if they miss a dose of Binosto 70 mg, they should take one effervescent tablet on the morning after they remember.
They should not take two effervescent tablets on the same day but should return to taking one effervescent tablet once a week, as originally scheduled on their chosen day.
4) Package
4 effervescent tabs/box
Alendronic acid 70mg
2) Indication
Treatment of postmenopausal osteoporosis
3) Dosage & Administration
Posology
The recommended dose is one 70 mg effervescent tablet once weekly.
Patients should be instructed that if they miss a dose of Binosto 70 mg, they should take one effervescent tablet on the morning after they remember.
They should not take two effervescent tablets on the same day but should return to taking one effervescent tablet once a week, as originally scheduled on their chosen day.
4) Package
4 effervescent tabs/box